Artivion/AORT

$23.75

1.27%
-
1D1W1MYTD1YMAX

About Artivion

Artivion, Inc. is a medical device company engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease, heart valve disease, aortic aneurysms, and dissections. The Company's segments include Medical Devices and Preservation Services. The Medical Devices segment includes sales of aortic stent grafts, surgical sealants, and On-X. The Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. It has four product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include BioGlue Surgical Adhesive products. It also sells or distributes PhotoFix bovine surgical patches.

Ticker

AORT

Sector

Healthcare

Trading on

NYSE

Industry

Medical Equipment & Supplies

CEO

James Mackin

Employees

1,500

Headquarters

Kennesaw, United States

Artivion Metrics

BasicAdvanced
$992M
Market cap
-
P/E ratio
-$0.26
EPS
1.73
Beta
-
Dividend rate
$992M
1.72546
$25.51
$12.16
197K
6.039
4.256
107.216
107.308
260.806
2.26%
-1.25%
-3.33%
-1.33%
2.695
3.365
92.899
15.13%
63.86%
11.81%

What the Analysts think about Artivion

Analyst Ratings

Majority rating from 5 analysts.
Buy

Price Targets

Average projection from 5 analysts.
12.63% upside
High $30.00
Low $25.00
$23.75
Current price
$26.75
Average price target

Artivion Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
7.7% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$97M
4.06%
Net income
$7.5M
-292.31%
Profit margin
7.7%
-285.1%

Artivion Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 310.77%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.08
-$0.24
-$0.10
$0.18
-
Expected
-$0.08
-$0.06
-$0.11
-$0.09
-$0.06
Surprise
5.26%
313.79%
-4.76%
-310.77%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Artivion stock?

Artivion (AORT) has a market cap of $992M as of May 29, 2024.

What is the P/E ratio for Artivion stock?

The price to earnings (P/E) ratio for Artivion (AORT) stock is 0 as of May 29, 2024.

Does Artivion stock pay dividends?

No, Artivion (AORT) stock does not pay dividends to its shareholders as of May 29, 2024.

When is the next Artivion dividend payment date?

Artivion (AORT) stock does not pay dividends to its shareholders.

What is the beta indicator for Artivion?

Artivion (AORT) has a beta rating of 1.73. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

What is the Artivion stock price target?

The target price for Artivion (AORT) stock is $26.75, which is 12.63% above the current price of $23.75. This is an average based on projections from 5 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Artivion stock

Buy or sell Artivion stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing